Noise-Induced Hearing Loss
12
2
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.3%
1 terminated out of 12 trials
83.3%
-3.2% vs benchmark
8%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Intervention for Hearing Health Among Native Americans
Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss
Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss
Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Protective Effects of EPI-743 on Noise-Induced Hearing Loss
Prevention of Noise-induced Hearing Loss
Micronutrients to Prevent Noise-induced Hearing Loss
Test of Hearing Health Education Programs for Farm and Rural Youth
Test of a Web-based Intervention to Promote Hearing Protector Use
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
Prevention of Noise-induced Damage by Use of Antioxidants